TIVC CEO Amends Form 4: 85,000 Options at $3.32, Vesting Clarified
Jennifer Ernst, Chief Executive Officer and Director of Tivic Health Systems, Inc. (TIVC), amended a prior Form 4 to correct the vesting schedule for a stock option grant.
Rhea-AI Filing Summary
Jennifer Ernst, Chief Executive Officer and Director of Tivic Health Systems, Inc. (TIVC), amended a prior Form 4 to correct the vesting schedule for a stock option grant. The amendment shows a grant of an employee stock option to purchase 85,000 shares of common stock at an exercise price of $3.32 with a transaction date of 08/06/2025. The option is exercisable under a corrected vesting schedule: 25% vests on the first anniversary of the grant and the remaining 75% vests in twelve equal quarterly installments so that 100% vests by the fourth anniversary. Following the reported transaction, Ms. Ernst beneficially owns 85,000 underlying shares directly.
Positive
- Corrective disclosure filed to amend an administrative error, improving transparency
- Clear vesting schedule confirmed: 25% at one year, then quarterly over three years
Negative
- None.
Insights
TL;DR: CEO amended filing corrects option vesting to a standard four-year schedule for 85,000 options at $3.32.
The amendment clarifies an administrative error in the original Form 4 and confirms the award structure: a single grant of 85,000 employee stock options with a $3.32 exercise price and a typical four-year vesting pattern (25% after one year, then quarterly over three years). This is a routine executive equity grant amendment to align disclosure with the actual award terms. The filing is informational and does not report cash proceeds or sales; it updates beneficial ownership disclosure to show 85,000 underlying shares owned directly after the reported transaction.
TL;DR: Amendment corrects disclosure; no new material transaction beyond the original grant details.
The Form 4/A addresses a clerical error in vesting schedule disclosure and restates the option terms. From a governance perspective, correcting public filings is standard practice to maintain transparency. The corrected vesting timeline is explicit and aligns with common executive incentive designs. The amendment does not introduce additional transactions or changes to ownership beyond clarifying vesting mechanics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Purchase) | 85,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. This Amendment No. 1 ("Form 4/A") to the Form 4 filed by the reporting person on August 8, 2025 (the "Original Form 4") is being filed to correct an administrative error, resulting in the incorrect vesting schedule for the stock option being included in the Original Form 4. As reflected in this Form 4/A, the stock option vests as follows: (i) 25% upon the first anniversary of the grant date, and (ii) the remaining 75% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Jennifer Ernst report on Form 4/A for TIVC?
How does the corrected vesting schedule for the TIVC option work?
What is Jennifer Ernst's role at Tivic Health Systems reported on the form?
When was the amendment filed and signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.